Clinical validation of a high-performance somatic exome sequencing assay: from target-enrichment strategy to variant calling
{{output}}
Clinical whole-exome sequencing (WES) has revolutionized clinical diagnostics by enabling scalable, cost-effective molecular profiling to detect somatic variants and identify novel therapeutic targets. In particular, the clinical evaluation of somatic variants... ...
